Antara Capital LP
Follow13F filer, CIK 1750183, New York, NY
Antara Capital LP reported $30,189 across 2 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-17.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001172661-26-001155
- Period
- 2025-12-31
- Reported value
- $30.2K
- Holdings
- 2
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 1
Largest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| CURRexited | -263,200 | -$442K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q4 2025
Share positions as resolved from 13F-HR 0001172661-26-001155, largest first. % of portfolio is the value over $30,189, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ASPIRE BIOPHARMA HLDGS INC …ASPIRE BIOPHARMA HLDGS INC COM | 202,897 | $26.8K | 88.65% | 0 | |||
| ASBPWASPIRE-LAKEWOOD HOLDINGS INC | 207,693 | $3.43K | 11.35% | 0 | Timeline |
Sold out in Q4 2025
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| CURRCURRENC GROUP INC | 263,200 | $442K | shares |
How Q4 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001172661-26-001155 | base | 2026-02-17 | acceptance time not in the bulk data set |